Microbiota–fibroblast crosstalk represents the missing link in skin barrier dysfunction and fibrosis
British Journal of Dermatology · 2026
DOI: 10.1093/bjd/ljag068 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Dermatology, 2026. Verfasst von Zhen Lin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Fibroblasts, Skin Microbiome, Skin, Skin Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Dermal fibroblasts are key cellular components of the skin stroma, primarily responsible for extracellular matrix synthesis and the maintenance of tissue structure and function. Beyond this canonical role, these cells also possess immune regulatory functions, enabling them to sense and integrate microbial cues to orchestrate cutaneous inflammatory responses, wound repair and fibrogenesis. The skin microbiome is a critical regulator of fibroblast homeostasis; its dysbiosis disrupts fibroblast–microbe crosstalk, leading to aberrant fibroblast activation and contributing to the pathogenesis of various dermatological conditions. Clinically, the burden of these disorders is substantial, and current therapeutic strategies targeting fibroblast dysfunction often yield limited efficacy. Fortunately, recent advances in deciphering the pathophysiological mechanisms underlying fibroblast–microbe interactions have highlighted critical molecular regulatory networks, opening new therapeutic avenues. Among these emerging approaches, interventions targeting the microbiota-fibroblast axis – such as probiotics, postbiotics and fibroblast-directed agents – hold considerable promise. Deciphering the nuances of this crosstalk is pivotal for advancing precision and regenerative therapies, with potential implications for cutaneous and systemic fibrotic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Plastic and Aesthetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Plastic and Aesthetic Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- University of Michigan Medical School, Ann Arbor, MI, USA.
ORCID-Profile: Gaofeng Wang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Lin, Z., Yang, L., Han, Y., Qi, C., Chen, L., Luo, Y., Lin, Y., Sweren, E., Chen, P., Alphonse, M. P., Garza, L. A., & Wang, G. (2026). Microbiota–fibroblast crosstalk represents the missing link in skin barrier dysfunction and fibrosis. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag068
Vancouver
Lin Z, Yang L, Han Y, Qi C, Chen L, Luo Y, et al. Microbiota–fibroblast crosstalk represents the missing link in skin barrier dysfunction and fibrosis. British Journal of Dermatology. 2026. doi:10.1093/bjd/ljag068
BibTeX
@article{Lin2026,
author = {Lin, Zhen and Yang, Lan and Han, Yiwen and Qi, Caiyu and Chen, Lu and Luo, Yuxuan and Lin, Yihan and Sweren, Evan and Chen, PeiYang and Alphonse, Martin P and Garza, Luis A and Wang, Gaofeng},
title = {Microbiota–fibroblast crosstalk represents the missing link in skin barrier dysfunction and fibrosis},
journal = {British Journal of Dermatology},
year = {2026},
doi = {10.1093/bjd/ljag068}
}
EUVIMED